Phase II trial evaluating efficacy of a Fitbit program for improving the health of endometrial cancer survivors.
Rahimy E, Usoz M, von Eyben R, Fujimoto D, Watanabe D, Karam A, Jairam-Thodla A, Mills M, Dorigo O, Diver EJ, Teng N, English D, Kidd E.
Rahimy E, et al.
Gynecol Oncol. 2021 Apr;161(1):275-281. doi: 10.1016/j.ygyno.2021.01.033. Epub 2021 Feb 5.
Gynecol Oncol. 2021.
PMID: 33551199
Clinical Trial.